Category Archives: Strategy
By Pharm Exec | Published: October 23, 2014
The recent termination of AbbVie’s deal to acquire Shire has “jolted the industry out of its reverie” by becoming pharma’s first major casualty of new US tax inversion legislation, says research and consulting firm GlobalData.
By Guest Blogger | Published: October 23, 2014
By Jim Miller. Exits from the CMO industry are a more recent development that seems to be picking up momentum. Examples of CMOs leaving the industry in the past year include the contract manufacturing units of Bayer and Boehringer-Ingelheim; Pharmalucence; and SCM Pharma. There have been two principal drivers of these developments: growing demand for […]
By Pharm Exec | Published: October 15, 2014
In this special issue of Pharm Exec Global Digest: Unlocking the true value of Big Data; Data privacy and the health sciences; In-silico modeling and real-word outcomes; and more… Click here to access the issue.
By Guest Blogger | Published: October 10, 2014
The National Institutes of Health (NIH) announced yesterday that it is issuing nearly $32 million in grants for the development of strategies to analyze and leverage biomedical data sets. The grants are part of NIH’s Big Data to Knowledge (BD2K) initiative, launched in December 2013. BD2K is funded from all 27 NIH institutes and centers, as […]
By Guest Blogger | Published: October 8, 2014
By Mark Perlotto. Thirty-nine years ago this past June, an article appeared in BusinessWeek that offered readers what was for its time a startling degree of foresight. Four paragraphs down, just above their first historic mention of what they called “the paperless office,” the authors of “The Office of the Future” passed along a prediction […]